American Kidney Fund Convenes Nation’s Kidney Community for 2024 Kidney Action Week™ March 18-22
18 mars 2024 09h47 HE
|
American Kidney Fund
ROCKVILLE, Md., March 18, 2024 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) kicks off its fifth annual Kidney Action Week™, the nation’s only free online conference that draws patients,...
American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Against Kidney Disease
15 mars 2024 08h59 HE
|
American Kidney Fund
ROCKVILLE, Md., March 15, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is pleased to announce its 2024 Class of Corporate Members who serve as strategic partners in AKF’s Corporate...
Unicycive Announces $50 Million Private Placement
14 mars 2024 07h03 HE
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive”), a clinical-stage biotechnology company developing therapies for...
Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT Conference
13 mars 2024 07h03 HE
|
Unicycive Therapeutics, Inc.
– Promising Preclinical Results in Delayed Graft Function of Acute Kidney Injury – – UNI-494 Phase 1 Single Ascending Dose Portion of Clinical Trial Complete – LOS ALTOS, Calif., March 13, 2024 ...
Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC)
07 mars 2024 16h12 HE
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant Patients
04 mars 2024 07h03 HE
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
Kidney Month: 31 Day of Action to Equip and Empower People to Fight Kidney Disease
29 févr. 2024 14h44 HE
|
American Kidney Fund
ROCKVILLE, Md., Feb. 29, 2024 (GLOBE NEWSWIRE) -- The first day of March marks the beginning of Kidney Month, a month in which the American Kidney Fund (AKF) will mark 31 days of action that will...
Where You Live Impacts Your Ability to Save a Life Through Living Organ Donation, According to the 2024 American Kidney Fund Report Card
22 févr. 2024 09h24 HE
|
American Kidney Fund
ROCKVILLE, Md., Feb. 22, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today released its fourth annual State of the States: Living Donor Protection Report Card with updates highlighting...
Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical Meeting
14 févr. 2024 07h03 HE
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
Urology Devices Market revenue to surpass USD 63 Billion by 2033, says Research Nester
12 févr. 2024 05h00 HE
|
Research Nester
New York, Feb. 12, 2024 (GLOBE NEWSWIRE) -- The global urology devices market size is expected to expand at ~7% CAGR from 2023 to 2033. The market is anticipated to garner a revenue of USD 63...